Biolase Profit Margin 2006-2018 | BIOL

Current and historical gross margin, operating margin and net profit margin for Biolase (BIOL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Biolase net profit margin as of December 31, 2018 is -46.62%.
Biolase Annual Profit Margins
Biolase Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.047B $0.046B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $64.581B 21.45
Align Technology (ALGN) United States $23.069B 58.73
McKesson (MCK) United States $22.369B 8.71
AmerisourceBergen (ABC) United States $15.906B 11.54
Laboratory Of America Holdings (LH) United States $15.059B 13.85
Cooper (COO) United States $14.268B 24.89
Cardinal Health (CAH) United States $13.932B 9.39
DENTSPLY SIRONA (XRAY) United States $11.273B 25.07
Henry Schein (HSIC) United States $9.167B 14.81
West Pharmaceutical Services (WST) United States $8.398B 40.53
Merit Medical Systems (MMSI) United States $3.425B 36.86
CONMED (CNMD) United States $2.284B 37.12
Patterson (PDCO) United States $2.065B 16.32
Atrion (ATRI) United States $1.634B 47.96
STAAR Surgical (STAA) United States $1.599B 133.93
Antares Pharma (ATRS) United States $0.446B 0.00
Invacare (IVC) United States $0.240B 0.00
Lifevantage (LFVN) United States $0.164B 22.06
Pro-Dex (PDEX) United States $0.064B 29.13
Endologix (ELGX) United States $0.063B 0.00
Retractable Technologies (RVP) United States $0.022B 0.00
Milestone Scientific (MLSS) United States $0.015B 0.00